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Measurement of Permeability
of the Cell Membrane to Water
ABSTRACT-The water permeability was measured for blood cells from normal subjects and for
blood cells from patients with leukemia. The method of measurement of the kinetics of water
influx employed a stopped flow apparatus. The method of calculation of results was based on
irreversible thermodynamics. The measurements and calculations were both performed with the
assistance of a computer. The water permeability of the leukemic cells was decreased from normal,
and the values were more variable than normal. Leukemia changes the structure of the cell
membrane.

RICHARD MOORE*, FREDERICK THORNBURGH**
DONGGYU JIN***

Cancer represents a derangement of the normal functions
of a cell. This derangement may affect the physiological
properties of the cell membrane. Cancer of the blood
(leukemia) may affect the membrane properties of circulating blood cells. If there is such an alteration, it might be
useful in predicting the response of a patient to chemotherapy, and hence, in selecting an effective anti-leukemic
drug.
Such an approach to the problem of predicting of drug
therapy is suggested in the acute leukemias for several
reasons. There are more drugs which are effective against
acute leukemias than against other cancers, such as solid
tumors. Lymphatic leukemia is very drug sensitive compared
to other types of leukemias. Sampling neoplastic cells is
simpler for leukemias than solid tumors.
One of the goals of oncology is to improve the chemotherapy of malignant disease, such as leukemia. Often, drug
effectiveness is evaluated on the basis of statistical considerations, using data from large scale clinical trials with many
drugs. The oncologist needs a procedure that could help
predict which drug, if any, would have the greatest chance
for success in the treatment of a specific patient. Ideally,
the diagnostic procedures should work in vitro with
micro-samples and produce results promptly. There is need
for such a predictive test in acute myelogenous leukemia
for example. There is a large number of c~ndidate drugs,
and all of them cannot be tried on a patient before a
successful one is found. Not only may the patient not
survive long enough for several drugs to be tested, but the
effect of a particular drug may be influenced by prior
chemotherapy.
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proliferative disease, such as leukemia, the drug must enter
the cell. Entrance may be affected by the normal permeability of the cell membrane to the drug as well as the
effect of the disease on the cell membrane permeability.
Penetration of the drug through the cell membrane determines the response of a cell to the drug, e.g., as methotrexate. If methotrexate enters, the cells respond to the
drug in cases of animal leukemia and human leukemia.
Kessel (1969) reported that alkalating agents, busulfan and
nitrogen mustard, entered cells, and this entrance was
associated with the response of the cell to the drug. Kessel
(1971) tested platelets and granulocytes from humans with
leukemia of unspecified type. If the drug affected the
capacity of the cells to incorporate labeled uridine or
thymidine into RNA, then the drug administration was
effective against the leukemia.
To be effective, anti-leukemia drugs must be taken up
and retained within leukemic blast cells. While within
the cells, they should have the maxium effect on the cell.
Vincristine is a drug useful in the treatment of acute
leukemia, and its efficacy is determined by the permeability of the cell wall. Complex procedures are necessary,
involving assay of the radiosiotopically labeled drugs, to
measure the concentration of the drug within the cell. We
hope to study one of the factors (membrane permeability)
upon which successful drug therapy depends. This paper
describes our approach to measuring membrane permeability.
Samples from human volunteers

Samples of peripheral blood were obtained from human
volunteers or from patients with several types of acute
leukemia. Two milliliters of blood were collected in EDT A
(ethylenediaminetetracetate) anticoagulant. One volume of
cells was mixed with 99 volumes of human blood plasma
of the same type and group as that of the patient. Three
milliliters of the resulting· 1% cell suspension were placed
in one syringe of a stopped flow apparatus, and ·a
"challenging" solution was placed in the other syringe. The
challenging solution was typed plasma which either was
undiluted or was diluted with distilled water to a known
hypo tonic concentration. All samples of plasma and distilled
water were degassed with a vacuum pump before using.
The appearance of selected samples of cells was examined
microscopically before the sample entered the stopped
flow apparatus and after the cells had been through the
instrument.
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Instrumentation

A cell suspension was placed in one syringe , and a
"challenging" solution was placed in a second syringe. The
syringes were placed in an Aminco-Morrow stopped flow
apparatus. To perform an experiment, compressed air forced
aliquots from each syringe through a "T"-shaped mixer
into an optical cuvette, and the flow was stopped. Simultaneously, an oscilloscope trace was initiated. Monochromatic light shown through the optical cuvette. The light
was multiply scattered by the cells, and the beam emerging
from the cuvette fell on the photocathode of a photomultiplier. The photomultiplier signal was amplified and
appeared at the beam deflection plates in a storage
oscilloscope. Water moved from the hypotonic suspension
medium into the blood cells, increasing the cell volume.
When the blood cell volume changed, the amount of light
scattering varied, and the phototube signal changed accordingly. A linear calibration related phototube signal to
erythrocyte volume at equilibrium. Selected curves traced
on the scope phosphor were photographed. The kinetics
of cell volume change, and hence of water movement, were
calculated from measurements of the photograph.
Distilled water was mixed with distilled water to provide
a reference trace. The response of the system indicated
whether the operation of the apparatus was satisfactory.
Instrument response was checked also by mixing two aliquots of a latex particle suspension, noting the resulting
oscilloscope trace, and comparing this trace with that
obtained on previous days.
Procedure of experiment

Experiments were performed in which erythrocytes were
challenged with a hypotonic plasma. The per cent optical
transmission was recorded as a function of time . Points
were selected on the recorded curve , and the coordinates of
the points were measured with a traveling microscope, and/
or with a coordinate reader. The coordinate reader had two
transparent cursors which move in perpendicular directions,
and each cursor bore a cross-hair. Each cursor was connected
to a potentiometer across which a stable and constant D-C
voltage was maintained. A fraction of the potentiometer
voltage was tapped, and this fraction was proportional to
the distance ot the cu1~or from a reference point. The
voltages tapped from the two potentiometers were the
input signals to two channels of a mini-computer. The computer was programmed to convert the two analog voltages
to digital signals, display the point defined by these two
coordinates on the screen of a cathode ray tube (to help
detect an operator's mistakes), format, and punch the
digital values of the coordinates of the points into paper
tape. Another program, used subsequently, read the paper
tape , printed the data. and used calibration constants to
scale the values to those of the ongmal photograph. The
program calculated the logarithms of the ordinates. A
method of data reduction was used (Frost and Pearson)
that did not require knowledge of the asymptote which
the curve approached. This elimination of the need to
estimate the unknown asymptote removed a source of
potential error from the calculations. However, this gain is
at the cost of being able to use only half the data points
for the regression analysis. The program performed a linear
regression on the points. It calculated the pseudo-first
order rate constant from the slope of the regression line,
the corresponding half time for the cell volume change, and
the osmotic filtration coefficient of the cell membrane. This
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calculation was based on a method described by Farmer
and Macey.
The data set was edited by removing the measurements
made during the first 150 milliseconds ( during which the
phototube signal did not represent cell volume change
only). The remaining data were fitted by the equation:
y = sum (Bi exp (-Ki t)) + A, in which i was I , 2, and 3
in successive calculations.
Reproducible and nonreproducible data photos

If erythrocytes were mixed with hypertonic medium ,
a single phase of volume change was usually seen. The first
150 milliseconds of data on photographs usually was not
reproducible. This was interpreted as being due to an artifact of mixing. The curve at times greater than 150 milliseconds was reproducible. This portion of the curve was
measured. If the measured points were plotted on semilogarithm paper, a single exponential usually fitted the
experimen,tal curve. The values calculated for the osmotic
filtration coefficient for cells from normal donors were
reproducible and were about 0.6 microns per minute per
atmosphere. The curves for the cells for patients with
leukemia were more variable. Some of these curves had
the same general shape as the curves from normal cells,
but the associated value of the half-hme of cell swelling
was longer, and the value of the osmotic filtration coefficient was generally lower than normal (3/4 of normal
in acute lymphocytic leukemia to I /5 normal in acute
myelogenous leukemia). Some of the experiments produced curves which were the mirror image of the expected
swelling curves, and we cannot explain these.
Membrane changes observed

Malignancy changes properties of the cell membrane.
Ambrose found that if the membranes of fibroblasts from
normal subjects touched , they formed an adhesion in the
region of contact. Fibroblasts from patients with sarcoma
lost this ability to form stable intercellular lesions. Sane!
and Serpick studied monocytes from patients with acute
monocytic or monomyelocytic leukemia . They found
membrane bonding between cells by "zipperlike" junctions.
The junctions exhibited reciprocal interdigita lions of plasmalemmal extrusions and areas of intimate contact between
surface membranes of the adjoining cells. These areas of
contact were different from sites of adhesion. They were
larger and they showed a specialized architecture, consisting
of facing, rigidly parallel membranes of the two cell
surfaces separated by an electron-lucent space 150 to 200
angstroms thick.
If stained with uranyl acetate , the
junctions appeared as two confronting trilaminar unit
membranes separated by perpendicular, ladder-like intercepts 30 to 50 angstroms in diameter, evenly spaced 90
to I 00 angstroms apart. Sane! and Serpick surmised
that "the induction or unmasking of unique, highly
specialized structural complexes in these leukemic cells ...
may be related to neoplastic modifications of the plasma
membrane or its extraneous coat".
The zipperlike
junctions were found in vitro. The altered membrane
bonding was not demonstrated in vivo, but it might occur.
The high incidence of infection with Pseudomonas
aeruginosa or similar organisms in leukemic patients is
consistent with altered cell membranes in vivo.
Kanno ( 1966) reported that such zipperlike junctions
were associated with selective permeability. Therefore,
altered membrane permeability might be expected in
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monocytic or myelocytic leukemia. However, none of the
above authors measured membrane permeability.
Altered membrane glycoproteins could contribute
to changes in permeability of outer and inner membranes
of tumor cells.
Such altered membrane glycoprotein
has been reported by a number of workers. Klein
et al. examined the lymphocytes of an 82-year-old male
with chronic lymphocytic leukemia. They reported that
cells from chronic lymphocytic leukemics have unusual
surfaces. IgM heavy chain (mu chain) and kappa light chain
immunoglobulins were found on the cell surfaces in
amounts sufficient to be shown by fluorescein-labeled
antibodies and fluorescence microscopy . About 80,000
lgM molecules were present on each lymphocyte. Klein
found no evidence that the immunoglobulins come from
other sources than the leukemic cell itself. The leukemia
cell synthesized its surface immunoglobulins. 1f these
molecules were located at sites where transmembrane
movement occurred (as if they moved from cell interior
to exterior through "pores") then their presence might
help to explain an altered membrane permeability of
lymphocytes from patients with leukemia.
Preud 'Homme and Seligman studied lymphocytes from
patients with leukemia. They found gamma-, kappa-, and
lambda , and usually also mu-chain determinants on
lumphocytes from patients with chronic lymphocytic
leukemia.
These determinants made the surfaces of
these cells immunologically different from the surfaces
of normal lymphocytes.
Rubin and Schultz corroborated this finding. Further,
they found a specific defect in ribosonal RNA processing
in lymphocytes of patients with chronic lymphocytic
leukemia. This reflected defective ''T" cells (thymusderived lymphocytes). They regarded chronic lymphocytic
leukemia as a fundamental abnormality in lymphopoiesis.
Holt et al., studied the surfaces of normal and leukemic
lymphocytes from patients with chronic lymphocytic leukemia. They found that the surface of the leukemic lymphocyte was considerably more resistant to ionic etching than
normal cells. This was due to loss of the physical hardness
and consequent increased resilence of the lymphocyte
surface. This alteration of the properties of the surface was
also evident from other measurements. They suggested
that alteration of phospholipid metabolism may produce
a micro-injury in the membrane and may be partly
responsible for the observed weakness of the membrane of
the leukemic lymphocyte.
Thomson found that lymphocytes from patients with
chronic lymphocytic leukemia were unusually resistant to
hypotonic shock. This implies that the membrane permeability to water was reduced.
Burrows reported that lymphocytes from patients with
chronic lymphocytic leukemia show decreased osmotic
fragility. The time to lysis was increased over normal ,
indicating decreased membrane permeability to water.
Hemplin reported that normal human leukocytes had
values of the osmotic filtration coefficient (L p) of
0.83 microns per minute per atmosphere . Leukocytes
from patients with leukemias had the following significantly
different values for L p
chronic lymphocytic
leukemia:
0.57;, acute myelogen ous leukemia: 0.47;
chronic myelocytic leukemia : 0.45. He found that the
following factors affected the value of L p : age of donor,
volume of the cell, volume of osmotically inactive material
Journal of; Volume Forty-two, 19 76

in the cell, and % granulocytes in the granulocyte-lymphocyte mixture. Hempling did not report examining erythrocytes.
Solomon has associated the water permeability with a
pore size . This drop in permeability in leukemia can be
interpreted as a dramatic decrease in membrane pore size.
It raises the following questions:
In which cell is pore size changed?
In which leukemias is pore size changed?
Does pore size decrease in cell leukemias?
If so, does it affect the progress of the disease?
When, in the course of the leukemia, does the pore
size decrease?
In order for an anti-leukemia drug to be effective,
must it be less than a certain critical size to enter
the cell?
Would entrance of the drug be potentiated by
another drug which may increase membrane
permeability?
The answers to these questions await further research.
The composition of the cell suspension solutions and of
the challenging solutions varied from laboratory to laboratory. No protein was present in the cell resuspension medium
or the challenging solution in most cases. Cells may
crenate in the absence of protein in solution, even if the
solution is isotonic. Other workers usually determined the
value of the osmotic filtration coefficient from a few
samples of cells.
In the reports found, it was not clear if the cells were
taken from patients prior to the initiation of chemo- or
radiation therapy, during, or after therapy, or in remission.
If the value of membrane permeability changed during the
course of the disease, the studies in the literature did not
monitor these changes. Rather, any such changes would
appear as excess variation in the measured value of
membrane permeability. The sampling schedule should be
coordinated with the treatment schedule, and permeability
measurements need to be interpreted in the context of the
patient's clinical status.
Combined with the other appropriate tests, the measurements of the cei'l membrane permeability might supply
useful information in the treatment of certain leukemias,
as giving diagnostic evidence for monitoring these effects of
drugs on the cells, predicting the effectiveness of drugs on
the patient's disease , or predicting the onset of a leukemic
crisis.
Osmotic filtration measured

We applied the technique to detecting a change from the
normal value of the osmotic filtration coefficient of the
cell membrane associated with acute leukemias. The value
of the osmotic filtration coefficient was measured for
erythrocytes from leukemic patients. The results from these
measurements indicated a decrease in the osmotic filtration
coefficient of erythrocyte membranes from patients with
acute leukemias. The values were significantly decreased
below normal. This finding is not inconsistent with the
hypothesis that disease effects the function and structure of
the cell membrane. The procedure may be helpful to the
oncologist; for example, in the selection of drug-responsive
patients. The procedure might enable the evaluation of the
probable resu lts of drug therapy, or the use of drug
combinations.
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